Areas › Focus, starting, and ADHD › Medication and how it works
Count good days, not unbroken runs. Whatever yesterday was, brilliant or a write off, the only live question is what can be done with today.
Streaks make one slip cost everything, so the missed night turns into a missed week and then the whole effort gets quietly dropped. Aiming for more good days over a month keeps a bad Tuesday as just a bad Tuesday. If you are helping someone else, notice how they talk about a lapse and offer the gentler count back to them, since the words they use about it tend to decide what happens next.
This explains how treatments work. Never start, stop or change a medication because of something you read here.
Qur’an and Sunnah
'My servants who have harmed yourselves by your own excess, do not despair of God's mercy' (Quran 39:53). If despair is refused even there, a broken run of early nights is nowhere near enough reason for it.
۞قُلۡ يَٰعِبَادِيَ ٱلَّذِينَ أَسۡرَفُواْ عَلَىٰٓ أَنفُسِهِمۡ لَا تَقۡنَطُواْ مِن رَّحۡمَةِ ٱللَّهِۚ إِنَّ ٱللَّهَ يَغۡفِرُ ٱلذُّنُوبَ جَمِيعًاۚ إِنَّهُۥ هُوَ ٱلۡغَفُورُ ٱلرَّحِيمُ
Say, ‘[God says], My servants who have harmed yourselves by your own excess, do not despair of God’s mercy. God forgives all sins: He is truly the Most Forgiving, the Most Merciful
Qur’an 39:53read it in the library
Translation: M.A.S. Abdel Haleem, The Qur'an, Oxford University Press, 2004.
What the research says
Real treatment rarely runs in a clean line. An open label study followed adults with ADHD through a year of ordinary care and found genuine benefit arriving alongside substantial dose adjustment and a real burden of side effects. It is observational rather than controlled, so it cannot prove what caused the improvement, and it does describe the texture well: the year that helped people was a year of changes and setbacks rather than a smooth run.
Fredriksen M, Dahl AA, Martinsen EW, Klungsøyr O, Haavik J, Peleikis DE. (2014). Effectiveness of one-year pharmacological treatment of adult attention-deficit/hyperactivity disorder (ADHD): an open-label prospective study of time in treatment, dose, side-effects and comorbidity.. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology doi
Strength of evidence: one line of research. A single study, or a theoretical account.
Why it works
When nothing is riding on a perfect run, one bad day stays one bad day instead of ending the whole attempt.
This one is still a draft. It is waiting on a scholar and a clinician to read it before it is published.
Near this one
If the medication question is the one burning a hole in your pocket, try holding it until last on purpose. Heard after everything else, the answer lands differently.
When a dose that was working seems to stop working in a growing child, check height and weight before you reach for the word tolerance. These medicines are dosed by body weight, and a child can simply have outgrown the dose.
New medicines will probably come from genetics and from the chemistry of the frontal lobes. None of it is close enough to be worth waiting for.